4-AcO-MET
4-acetoxy-N-methyl-N-ethyltryptamine
1Provenance card
the boundary, as counts
Sources
1714 with DOI
2 strong · 12 moderate · 3 weak
Compilations
12026-04-26T12:49:03.299Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
31last ruled 2026-06-04
0 awaiting a ruling
Issued documents
62026-10-19T20:29:51.174Z
notice · info card · emergency
Searches
192 with no results
queries and counts on the build
Claims checked
4836 supported
36 supported · 12 not
Correspondence
0received
consent field ships in Phase 4
Edges
180
derivations recorded for this entity
Complete over 17 sources, 1 compilation, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/4-aco-met/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued emergency
- 2026-10-19issueIssued info_card
- 2026-10-19issueIssued notice
- 2026-09-24srcTentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS
- 2026-09-24srcOpioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
- 2026-09-24srcIn-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5'-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin
- 2026-09-24srcPsychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)
- 2026-09-24srcTolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT2A Receptor Agonists in Mice
- 2026-09-24srcReceptor Binding Profiles for Tryptamine Psychedelics and Effects of 4-Propionoxy-N,N-dimethyltryptamine in Mice
- 2026-09-24srcA Fatality Related to Two Novel Hallucinogenic Compounds: 4-Methoxyphencyclidine and 4-Hydroxy-N-methyl-N-ethyltryptamine
- 2026-09-24srcPsilacetin derivatives: fumarate salts of the methyl-ethyl, methyl-allyl and diallyl variants of the psilocin prodrug
- 2026-09-24srcPharmacologic Activity of Substituted Tryptamines at 5-HT2A, 5-HT2C, 5-HT1A Receptors and SERT
- 2026-09-24srcAdverse effects of psychedelics: From anecdotes and misinformation to systematic science
- 2026-09-24srcIdentification of New Psychoactive Tryptamines 4-OH-MET and 4-AcO-DMT Using High Resolution Mass Spectrometry and Nuclear Magnetic Resonance Spectroscopy
- 2026-09-24srcTherapeutic use of psilocybin: Practical considerations for dosing and administration
- 2026-09-24srcToxicology and Analysis of Psychoactive Tryptamines.
- 2026-09-24srcHuman Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by LC-HRMS/MS
- 2026-09-24srcDifferential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes
- 2026-09-24srcTiHKAL #21: 4-HO-MET (Erowid online reproduction)
- 2026-09-24src4-AcO-MET (HandWiki)
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-04-26revisionRevision 1
- 2026-04-26absenceSearched ClinicalTrials.gov for "4-AcO-MET tryptamine psychedelic" — no results
- 2026-04-26absenceSearched PubMed for "4-AcO-MET 4-acetoxy-MET tryptamine psychedelic" — no results
- 2026-04-26genGeneration — pipeline-v5pipeline-v5
- 2026-04-26rungeneration run
The same entries, as forms: six forms.